LEXX (lexariabioscience.com) Sof foyda

Lexaria Bioscience (LEXX) korporativ emblemasi va logotipi

Lexaria Bioscience kompaniyasining tor patent litsenziyalash nishasini egallashga bo'lgan intilishi xavfli ko'rinishi mumkin, biroq kompaniyaning sof foyda ko'rsatkichlari boshqacha tendentsiyani namoyish etmoqda. -0.01 belgisi hisoblangan daromadlar modelning barqarorligini tasdiqlovchi darajani ko'rsatadi. Bu GDP dan mustaqil bo'lgan uzoq muddatli R&D shartnomalariga va foydani taqsimlash istiqbollari orqali yetakchi kimyogarlarni jalb qilishga asoslangan.

LEXX (lexariabioscience.com) Kompaniyaning sof foydasi tarixi 04.07.2022dan 29.10.2026gacha

lexariabioscience.com (LEXX) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Lexaria Bioscience Corp.|LEXX - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Lexaria Bioscience Corp.|LEXX - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Lexaria Bioscience|LEXX - Kompaniyaning balans qiymati|Bozor qiymatining balans qiymatiga koeffitsiyenti lexariabioscience.com|LEXX - Kompaniyaning yakuniy aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Jamlagan qarzning kapitalga nisbati Lexaria Bioscience|LEXX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Lexaria Bioscience Corp.|LEXX - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Lexaria Bioscience Corp.|LEXX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari Lexaria Bioscience|Tezkor likvidlik lexariabioscience.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
LEXX - Sof foyda
Fundamental baholash:LEXX Lexaria
Lexaria Bioscience Corp yetakchi tovari

DehydraTECH texnologiyasining turli terapevtik sohalarda litsenziyalanishi Lexaria Bioscience (LEXX) kompaniyasining operatsion samaradorligiga bevosita ta'sir ko'rsatib, kiruvchi pul oqimlari hajmini belgilaydi. Kompaniyaning sof foydasini tahlil qilish orqali investor barcha operatsion xarajatlar va soliqlarni chegirib tashlagandan keyingi yakuniy moliyaviy natijani baholaydi, bu esa real biznes o'sishini vaqtincha to'xtashdan farqlash hamda kapital barqarorligini baholash imkonini beradi.

Asosiy raqobatchilar

Sof daromad Haleon Corp|KVUE (Kenvue Inc.) - Sof foyda|Sof foyda veronapharma.com|Sof daromad MENS (Jyong Biotech)|LGND (Ligand Pharmaceuticals Incorporated) - Yakuniy foyda|Kompaniyaning sof foydasi Amneal Pharmaceuticals Inc AMRX|Perrigo Corp (PRGO) - Kompaniyaning sof daromadi|ALVO: Sof daromad|liquidia.com - Soliqlar to‘langandan keyingi foyda|GLPG: Sof foyda|ANI Pharmaceuticals Inc - Yakuniy foyda|MNKD (MannKind Corp.) - Sof foyda|Kompaniyaning sof daromadi Amphastar Corp AMPH|Kompaniyaning sof foydasi Pacira BioSciences (PCRX)|SPRY (ars-pharma.com) - Yakuniy foyda|Kompaniyaning sof foydasi Theravance Biopharma, Inc. TBPH|Aquestive Therapeutics Inc - Kompaniyaning sof foydasi|scPharma - Sof foyda|Kompaniyaning sof daromadi Tectonic Therapeutic, Inc.|TNXP (Tonix Pharmaceuticals) - Sof daromad|Kompaniya foydasi SXTC|EPRX (Eupraxia Pharmaceuticals, Inc.) - Sof foyda|Sof foyda BioHarvest Sciences, Inc.|Kompaniyaning sof foydasi Invizyne Technologies, Inc. (EXOZ)|ORMP (oramed.com) - Yakuniy foyda|Sof foyda ENTX (Entera Bio)|Sof moliyaviy natija ipatherapeutics.com (HYFT)|ABVC BioPharma, Inc. - Sof foyda|CPIX - Sof foyda|QNTM (Quantum BioPharma Limited) - Sof daromad|FibroGen Corporation - Yakuniy foyda|TELO (Telomir Pharmaceuticals) - Sof foyda|Kompaniyaning sof foydasi RANI|Sof foyda SNYR|Sof moliyaviy natija rallybio.com|Kompaniyaning sof foydasi Pulmatrix Corp PULM|Pheton Holdings Limited (PTHL) - Kompaniyaning sof daromadi|APM - Kompaniyaning sof foydasi|Sof moliyaviy natija lyratherapeutics.com LYRA|IBO: Sof foyda|Sof daromad TNF Pharmaceuticals, Inc.|YCBD (cbdMD Inc.) - Sof foyda|PainReform Corp (PRFX) - Sof moliyaviy natija|Sof foyda CYTO|LIPO - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi OptiNose OPTN|PIRS: Kompaniya foydasi|Procaps Group SA - Sof foyda|Petros Pharma (PTPI) - Sof daromad|QLI: Sof foyda|Kompaniyaning sof daromadi acelyrin.com (SLRN)|Kompaniyaning sof foydasi TFF Pharmaceuticals, Inc.